Table 2 Clinical outcome comparisons between the baseline cohort (2011–2013) and the evaluation cohort (2014–2016)
Baseline cohort 2011–2013 | Evaluation cohort 2014–2016 | |||
|---|---|---|---|---|
n | % | n | % | |
CABG | 184 | 128 | ||
120-day mortality | 1 | 0.5 | 0 | 0.0 |
CVA | 1 | 0,5 | 0 | 0.0 |
DSWI | 3 | 1.6 | 1 | 0.8 |
Surgical re-exploration | 10 | 5.4 | 6 | 4.7 |
PCI | 636 | 527 | ||
30-day mortality | 9 | 1.4 | 5 | 0.9 |
Urgent CABG | 2 | 0.3 | 0 | 0.0 |
MI | 3 | 0.5 | 5 | 1.0 |
Coronary artery diseasea | 810 | 643 | ||
Mortality | 10 | 1.2 | 5 | 0.8 |
Complications | 17 | 2.1 | 11 | 1.8 |
Event-free survival (short-term) | 780 | 96.7 | 603 | 97.4 |